facilities. With trypanosome infections, or with most bacterial infections, results are obtained in a few days. A tuberculous infection in the most suitable animals, guinea pigs and rabbits, may last for the better part of a year, and the single experiment is not ordinarily terminated until all of the animals have died.
Ten years ago our ideas of chemotherapy were based mainly on Ehrlich's original principle of selective affinities between the bactericidal chemical and the bacterial protoplasm, made effective by a lack of affinity between this chemical and the protoplasm of the host. There were plenty of substances that would kill tubercle bacilli in cultures, and many that even in great dilution would inhibit their growth. The problem was to find some way of getting these substances into the tubercle in sufficient concentration to be at least inhibitory to the growth of the tubercle bacillus without being too damaging to the more delicate cells of the host. It was recognized from the start that there were two major obstacles to the accomplishment of this purpose. One was the fact that the tubercle bacillus was more resistant to injury than most bacteria not so well armored with wax. The other was that the avascular character of the ordinary tuberculous lesions rendered them less accessible to chemotherapeutic agents than the normal tissues that we did not want to injure. To offset these drawbacks there were certain potential assets.. One was the possibility that the avascular nature of the tubercle might permit accumulation and retention of the chemotherapeutic agent in the necrotic center, just as calcium and cholesterol accumulate in tubercles. The other was the definite benefit that had been obtained in the treatment of leprosy. If a chemical agent in chaulmoogra oil could check the attack of the acid-fast leprosy bacillus, it was perfectly possible that something might do as much to the tubercle bacillus. With these facts to give encouragement, and Ehrlich's principles to lead the way, we started out on the laborious task of seeking a specific chemotherapeutic agent that might prove to be at least as valuable as is chaulmoogra oil in leprosy, if not as specific as is salvarsan in syphilis.
The facts that had been accumulated in 1922 and duly presented in The Chemistry of Tuberculosis may be briefly summarized as follows: No substance had yet been found that exerted any definite chemotherapeutic effect in tuberculous animals. Most of the compounds tried generally shortened the life or decreased the resistance of the animals tested, although a few seemed to be somewhat bene-ficial to the extent of lengthening the average life of a series of tuberculous animals or decreasing the dissemination of the disease in infected animals. Nothing had been found that would cure tuberculous infection in guinea pigs or rabbits. However, it was recognized that this was possibly an unreasonably severe requirement, in view of the low resistance of these animals, especially when compared with tuberculosis in human adults, which is generally a reinfection or relighting of infection in a partially immune host. No one had then, or has yet, devised a satisfactory experimental test animal to correspond closely in resistance to the human consumptive; man alone has classical phthisis pulmonalis.
The Permeability of Tubercles Certain definite things had been established of more or less value as a working basis for chemotherapeutic study. The possibility of getting chemical agents into tubercles had been studied. Loeb and Michaud* had shown that iodides entered tubercles readily. Wells and Hedenburg confirmed this, but found that it was not a special case. They demonstrated that any necrotic tissue, equally whether tuberculous caseation or anemic necrosis, as well as the fluids of suppuration and exudation, is readily permeable to any crystalloid dissolved in the blood, so that there tends to be an equilibrium between the crystalloids of the blood and the necrotic tissue or exudate. The soluble salts studied by them entered and left the tubercles equally readily, not tending to accumulate or to reach a higher concentration than in the blood. Such a large colloidal molecule as egg albumin would not diffuse into the tubercles, but DeWitt, Lewis, and others found that not only crystalloidal dyes but also dyes of small colloidal dimensions might enter tubercles. Corper found that dyes selectively accumulating in fats (Sudan III, Scarlet R) did not enter the fats in tubercles in living animals nor into the fatty substance of the tubercle bacilli, although these dyes saturated the fat in the adipose tissues. He also demonstrated, what seems to be a matter of much importance in chemotherapy, that soluble salts of metals (he studied chiefly copper salts) when injected into animals tend to go into a colloidal state, either as metals or protein compounds, and to behave like the same metals injected as colloids-hence they do not readily enter caseous tubercles.
The failure of fat-soluble stains to enter tubercles and tubercle bacilli in tubercles was a blow to the logical hope that the fatty nature of the tubercle bacillus might furnish a vulnerable spot in its armor. This was accentuated by the observation by Hope Sherman that fat stains do not readily stain tubercle bacilli, while such dyes as basic fuchsin, eosin, and methylene blue, which are not fat dyes, stain them readily. Also DeWitt and Sherman found that, contrary to expectation, fat-soluble antiseptics are relatively ineffective on tubercle bacilli, and fat-insoluble antiseptics are effective.
ChJiemotherapeutic Dye Compounds Many dyes and other substances, especially if in colloidal state, are picked up by macrophages, and as the periphery of tubercles contain many suchi phagocytic cells these substances accumulate about the tubercles, but not inside where most of the tubercle bacilli are.
When Lewis demonstrated that trypan red penetrates to the caseous center of fully formed tubercles, and DeWitt found that trypan blue and methylene blue also penetrated the caseous material, the possibility of getting dyes in contact with tubercle bacilli was established.* Lewis found that azo and eurhodine dyes as a group inhibit the growth of tubercle bacilli in cultures somewhat specifically. But trypan red and trypan blue, although both are azo dyes and able to penetrate tubercies, did not cure tuberculous guinea pigs or stop the progress of the infection even when the animals were saturated with the dyes. Since these dyes penetrate the tubercies so well, DeWitt tried to use them as vehicles to carry inhibitory agents to the bacilli.
Many compounds of the dyes were made with silver, copper, iron, and mercury, but none of them cured tuberculous guinea pigs; only the mercury salt seemed to decrease somewhat the rapidity and extent of the infection. Lewis was equally unsuccessful with compounds of Niagara blue, trypan blue, and trypan red, combined wit71 iodine, phenol, and other substances, using tuberculosis of the rabbit's eye as the test infection. Also several diazo creosote dyes werc made, none being curative, but some of which slightly prolonged life. As methylene blue is a dye that penetrates tubercles readily * It is intcresting to find a German investigator in 1929 exulting over his demonstration that a dye will enter caseous tubcrcles (Beitr. z. Klin. Tuberk., 1929, 72, 184) and a reviewer mentioning this as one of the important discoveries of the year.
DeWitt made many compounds with this dye as a vehicle to introduce antiseptics into tubercles, some of which seemed to decrease the extent of tuberculosis in the guinea pig, although not curative. She could not corroborate von Linden's claims for the great therapeutic value of methylene blue iodide. We also had prepared for her testing many compounds of mercury with dyes and tried their effects in great numbers of tuberculous guinea pigs. In some sets of experiments certain mercurialized dyes (especially mercury trypan blue, methylene blue and methylene green mercuric chloride), seemed to reduce definitely the spread and rapidity of the tuberculous infection. But it was not always possible to secure this same apparently beneficial result when the experiment was repeated a year later with a different lot of animals and a different strain of tubercle bacilli.
Guaiacol and Creosote
These drugs had once had a great vogue in the treatment of pulmonary tuberculosis, and the drug factories put out for use in tuberculosis a vast number of compounds with a guaiacol or creosote nucleus. However, our experiments had shown that creosote and guaiacol are not strongly bactericidal for the tubercle bacillus, and that it requires a concentration of 1: 2000 creosote or guaiacol even to inhibit growth in cultures, 1: 1000 being unable to kill in 24 hours' exposure. Chemotherapeutic experiments in guinea pigs with creosote, guaiacol, creosol, thiocol, styracol, orthocresol, metacresol, paracresol, and thymol all failed to show any recognizable good effect on the course of the tuberculosis, and the following decade has added no more evidence of chemotherapeutic value in this series of compounds.
Chaulmoogrates and Morrhuates Naturally the success in the treatment of leprosy with chaulmoogra oil and its constituents aroused hope that these substances might also give help in tuberculosis, especially as Walker and Sweeney had found that chaulmoogra oil contains substances about I 00 times as bactericidal as phenol, and specific for acid-fast bacilli. However, Walker found no evidence that the chaulmoogric acid entered tuberculous lesions, and his experimental therapeutic results were largely negative. Culpepper and Ableson tested the ethyl esters of four acids obtained from chaulmoogra oil on tuberculous guinea pigs, and reported marked beneficial effects. Despite this, however, the more recent literature fails to show any striking effect in either experimental or clinical tuberculosis from the use of the chaulmoogrates. Similar lack of observable benefit has been the outcome of the attempts to treat tuberculosis with the sodium salt of morrhuic acid from cod-liver oil, which Rogers thought would dissolve the fatty sheath of tubercle bacilli. The same has been the fate of numerous other drugs that were advocated as solvents of tubercle bacillus waxes, such as choline and compounds thereof, taurine, xylene, and terpenes of various sorts.
A rsenicals Ehrlich's success with arsenicals naturally incited interest and hope in organic compounds with metals. Arsenic had long been used in tuberculosis, mainly for its effect on general nutrition and tissue metabolism, for arsenic has been called "the digitalis of metabolism". The possibility of specific arsenical treatment of tuberculosis was made remote when Arkin and Corper tested sodium arsenite, sodium cacodylate, atoxyl, arsacetin, and neosalvarsan for tuberculocidal power, and found none. They found that arsenic did not accumulate in the tuberculous tissues of experimental animals. M. I. Smith likewise found but little inhibiting effect on tubercle bacilli in vitro, and no effect on guinea pig tuberculosis, from neoarsphenamine and silver arsphenamine. Since that time there seems to have been little attention paid to the possible use of arsenicals in the chemotherapy of tuberculosis. But it is to be mentioned that many syphilitics have been treated and cured with arsenicals without being cured of a coexisting tuberculosis.
Copper Therapy In 1922 there was great interest in copper, which had been used for many decades previously without showing any convincing evidence of value. The interest had been stirred up by a series of papers, beginning in 1912, by Grafin von Linden and some German clinicians whom she had apparently fired with her own enthusiasm. She used particularly a compound of copper with lecithin, promptly marketed with a trade name in true German style, and claimed that copper was a specific bactericide for tubercle bacilli, and that copper treatment cured tuberculosis in man and beast. Some very good press notices were obtained for a Japanese copper specific for tuberculosis, cyanocuprol (Koga), with a composition that sounds unwholesome, i.e., two parts of potassium cyanide and one part of copper cyanurate.
But DeWitt and Sherman found that it took a 5 per cent concentration of copper chloride to kill tubercle bacilli in 24 hours' exposure. Even 25 per cent CuCI2 did not kill all the tubercle bacilli in clumps immersed in the solution for 24 hours! Corper found that copper did not heal tuberculous rabbits and guinea pigs. He also found that copper did not enter the tubercles, for no matter in what form it was injected it promptly became colloidal copper, which was taken up by phagocytes and did not diffuse into caseous tubercles.
The interest that had been stirred up by the extensive advertising of von Linden's and Koga's preparations died out almost as fast as it arose, and since 1923 little has appeared in the literature about copper and tuberculosis, and nothing that arouses new interest. This sudden neglect is convincing evidence as to the lack of real value in copper therapy.
Mercurials
From time to time in old medical history the use of mercury compounds in tuberculosis has been advocated, but not long pursued. It is to be considered that the old physicians, who mercurialized their patients so devoutly-"The doctor comes with right good will But ne'er forgets his calomel"-did not seem to note that mercury cured their many consumptive clients with any striking regularity.
Very little had been done in trying to utilize mercurial compounds as true chemotherapeutic agents. In 1889 Cornet tried to cure tuberculous guinea pigs with that popular antiseptic, bichloride of mercury, this being one of the earliest chemotherapeutic attempts in the treatment of tuberculosis on the basis of known bacteriological action. Koch also found that mercury itself would not cure tuberculous guinea pigs. But DeWitt found that among many compounds of dyes with heavy metals that she had prepared for therapeutic testing, the most definite effects were produced by the mercury dye compounds. She found that mercury trypan blue had a high bactericidal action on tubercle bacilli, and it seemed to have more effect in reducing the spread of lesions and prolonging the lives of tuberculous animals than anything else that she tested. Methylene blue mercuric chloride, methylene green mercuric chloride, and a few other mercurial compounds of dyes and mercuriated phenols and anilines, were found to have distinctly beneficial but not curative effects. With less extensive controls DeWitt might have been misled into making a less conservative statement than the one in which she summed up her results: "No mercurials have cured tuberculosis in any guinea pig, but some of the results have seemed more favorable than have resulted from any other metal or from any other compound so far investigated in this laboratory. This seems to make the hope possible that some compound of mercury may yet be developed which may combine low toxicity with high bactericidal or bacteriostatic power and with lower organotropism and thus have high chemotherapeutic power in tuberculosis."
This line of work has not been continued since Dr. DeWitt's death, but her observations contain suggestions for further study. Paul Lewis also abandoned tuberculosis work in 1923, leaving the Phipps Institute to work on other problems in the Rockefeller Institute until the time of his lamented death from yellow fever. Since that time there has been no further systematic investigation of the possibilities of developing specific chemotherapeutic dye compounds with tuberculocidal properties.
Gold in Chemotherapy
Gold has been used in the treatment of tuberculosis (and almost everything else) since most ancient times, I suppose largely because of its precious character and royal standing. As a chemotherapeutic possibility it dates back to 1890 when Robert Koch found it to be a most potent agent against tubercle bacilli in cultures, gold cyanide inhibiting growth in dilutions of 1 to 2,000,000. But he found that it would not cure tuberculous animals. Shortly after this J. B. White thought that he did get some benefit in animals and in patients by using the double chloride of gold and sodium, combined with iodide of manganese, and after this numerous gold salts were recommended for consumption without any convincing proof of efficiency. The first extended study of the chemotherapeutic possibilities of gold was made between 1912 and 1916 by Spiess and Feldt. These authors considered gold cyanide and gold potassium cyanide too toxic for use in human patients. As cantharidin had earlier been found to have a marked affinity for tuberculous tissues, they conceived the idea of reducing the toxicity of the cantharidin and using it as a carrier for the specific gold cyanide. They were able to reduce the toxicity of the cantharidin 700 times without altering its affinity for tubercles by condensing it with ethylenediamine. This compound was quite nontoxic and combined readily with gold cyanide. They used first the auric salts but found them 100 to 1000 times less efficacious than the aurous salt, and therefore in their later work they used mono-cantharidyl-ethylenediamine-aurous-cyanide under the name "Aurocantan". Although they believed that they had demonstrated distinct chemotherapeutic effects in experimental animals, they found the clinical use of the gold cantharidin compound not very satisfactory. So Feldt has continued to try out various gold compounds, seeking one that might be less toxic without loss of the distinct tuberculocidal power of the gold ion.
DeWitt, Cadwell and Leavell investigated the therapeutic value of various gold salts in experimental tuberculosis in guinea pigs. The treatment was given by feeding, by subcutaneous injections and by intracardiac injections. They also determined the distribution of the gold in the normal and tuberculous tissues by analysis of the tissues.
DeWitt and Sherman had found that 1 part in 1000 of gold chloride is required to kill the tuberde bacilli, while I per cent solutions of gold tricyanide were not always able to kill all the organisms. However, they found, as did Koch, that the gold cyanide completely inhibited growth of the tubercle bacillus in the test-tube in a dilution of 1 in 2,000,000. Feldt states that in vitro these organisms develop a tolerance to the gold salts, while Shiga reported that tubercle bacilli developed no tolerance to gold salts. In DeWitt and Sherman's experiments, tolerance developed so slowly as not to be an important factor in the treatment of the disease in guinea pigs. Both the simple gold cyanides and the cantharidylethylenediamine aurous cyanide recommended by Spiess and Feldt were used and no, or very little, effect was seen on the disease, except that life in general was shorter and the disease more pronounced in the treated animals than in the controls. The amounts of gold found by analysis in the liver, spleen and lungs and other sites favored by tubercles in the animals treated by DeWitt are many times the concentration necessary in the test-tube to inhibit growth completely. The fact that tubercle bacilli grow luxuriantly in organs containing such an amount of gold is apparently explained by microchemical studies of the tissues of tuberculous animals and men treated with gold salts, which show that the gold is not in the tubercles where it might act upon the bacilli, but outside the tubercles in the reticulo-endothelial cells.
As most of the facts mentioned in the preceding paragraphs were known in or before 1923 the excitement aroused in some quarters in 1924 by M0llgaard's claims for "sanocrysin" seems to reflect on either the information or the judgment of the enthusiasts. The careful, detailed studies of Feldt, and of DeWitt and her co-workers, had given a sound basis of knowledge concerning the behavior and effects of gold compounds in the normal and in the tuberculous animal. As sanocrysin is merely an inorganic salt of gold, a double thiosulfate of gold and sodium, with the gold in trivalent form, (S2O3Au) Na2O, those familiar with the previous work on gold compounds could anticipate no properties not exhibited by the other gold salts already studied. It was already recognized that gold, in common with other metallic poisons, when introduced into the tuberculous animal leads to acute intoxication, associated with hyperemia, hemorrhage and edema about the tuberculous lesions, much resembling the reaction to tuberculin. It was appreciated that this effect might, under certain conditions, have possible therapeutic value whether induced by chemicals or tuberculin. There was no good evidence that gold has anything resembling a specific chemotherapeutic effect on the tubercle bacilli. Ehrlich's demand for "magic bullets" to destroy the invaders was not met even by gold missiles. Therefore any therapeutic value in gold salts must lie in the tuberculin-like effect, and there was much reason to doubt that a mineral poison would prove as safe an agent as tuberculin itself. The situation was well summarized by DeWitt in her concluding statement: "From all the experiments, we may conclude that the use of gold salts is not without danger. When active, their action seems associated with marked hyperemia and possible hemorrhages in the neighborhood of the tubercles. This tuberculin-like reaction might, if uniform and if it could be regulated and relied upon, produce certain beneficial connective tissue changes in the neighborhood of the tubercle, but the regulation seems too difficult and dangerous to make gold therapy ever a treatment of choice."
There is little justification for M0llgaard's idea that the toxic effects seen in tuberculous men and animals given sanocrysin, result from tuberculin liberated from tubercle bacilli killed by the drug. It has been observed that gold treatment often produces a lighting up of old tuberculin skin reactions, but it is not known whether this depends upon the setting free of tuberculin, or on hyperemia in the sensitized capillaries from the toxic action of the gold, or is a nonspecific allergic reaction either to disintegration products of the tubercle or to gold protein compounds. The belief that a specific antitoxic serum could be prepared to counteract tubercle bacillus endotoxins was contrary to immunological principles, and has not been supported by subsequent experience. More probably the toxic effects observed in sanocrysin treatment, to the extent that they are produced more in tuberculous than in normal animals, result from disintegration by accelerated autolysis in the tuberculous lesion, and increased absorption because of the hyperemia. This seems to be analogous to the effect of mercury and bismuth in hastening autolysis of syphilitic lesions independent of any action on the spirochete. The greater toxicity of sanocrysin in tuberculous than in normal animals is no evidence of a specific tuberculocidal effect. It may depend, according to Peterson and Levinson, on the presence in tuberculosis of an increased permeability of the endothelium, which is increased transiently by small doses, followed by a relative impermeability. Many other substances, from peptone to copper, behave like gold in that they produce different effects in tuberculous and non-tuberculous animals.
There is no evidence that sanocrysin has any particular virtue as a bactericidal agent; like all gold salts it has a high inhibitory value, but it has no noticeable bactericidal effect even in concentrations as great as 1: 2000 for 2 hours. Its inhibitory effect is largely prevented by the presence of blood proteins, e.g., in experiments with blood clots.
Early claims of a marked capacity to cure tuberculosis in rabbits, even with sterilization of the lesions, have not been substantiated by later investigations. Neither has confirmation been furnished the theory that sanocrysin behaves differently from other gold salts in the animal body. Hansborg has demonstrated that in sanocrysin treatment the gold promptly loses its easily diffusible character, and behaves like other heavy metals, being held and slowly excreted so that it may be detected in urine and stools after eight months. Gallinal found abundant gold microchemically in the tissues of a person who had last received sanocrysin ten months before death. In dogs it is excreted in the urine for at least 30 days, producing the usual toxic effects of metallic poisons, i.e., albuminuria, vomiting, diarrhea. Possibly somewhat more gold is retained in the tuberculous than in normal animals, and histological evidence supports this view.
Both microscopic and analytical studies have shown that sanocrysin treatment leads to much the same gold distribution in the organs of tuberculous or normal animals, produces about the same toxicological and therapeutic effects, and exhibits no particular distinction from the numerous other gold compounds that have been investigated. The gold seems to be taken up chiefly in the reticuloendothelial cells. It has been shown that introduction of small amounts of foreign materials of many sorts into these cells stimulates their immunological activity, and this may explain some of the effects of metallic and dye therapy in tuberculosis and other diseases.
German investigators and chemical houses are putting out numerous new gold compounds in the search for one that will have the minimum toxicity without loss of the tuberculin effect, and they may be trusted to continue doing so. But as yet there seems to be no reason to hope that gold compounds will be found to have any specific chemotherapeutic effect, in view of the fact that the gold does not enter the tubercles in appreciable amounts. On the other hand, many clinical studies indicate that gold salts have a certain therapeutic value, when properly used in selected cases. This value they seem to owe solely to their tuberculin-like effect on the tuberculous lesions, and there is much reason to believe that this effect can be equally well secured with less danger by proper use of tuberculin. And certainly, review of the large amount of literature on the clinical use of sanocrysin and other gold compounds shows that even in the reports of the enthusiasts the claimed effects are not usually striking. There are plenty of testimonials to throw doubt on the actual value of gold therapy, and also numerous objections to its dangers. (See Amberson, McMahon, and Pinner: Am. Rev. Tuberc., Oct., 1931.) Sanocrysin does not evade the general hazard of metallic poisons, producing intestinal, cutaneous and, especially, renal lesions.
Most careful observers will probably agree with the statement of Unverszagt: "The improvement in pulmonary tuberculosis after gold therapy in general is not much better than is to be obtained merely by a climatic cure. However, there is often shown a decrease in the number of bacilli in the sputum. As a stimulation therapy, not a chemotherapy, in suitable cases, gold therapy is an addition to our methods of treatment, although it has not fulfilled the great expectations it has aroused." In view of the foregoing general considerations and the experimental nature of the work with numerous other new gold compounds, it is not profitable to give extended consideration to all the reports now available. We may mention the observations of Fischer that in order of decreasing toxicity are: triphal (sodium auro-thiobenzimidazole carboxylic acid); sanocrysin (sodium gold thiosulfate); solganol (C7HuOuNS3Na2Au); and lopion (auroallylthioureabenzoate of sodium). Feldt has also described some new gold compounds which are but one-tenth as toxic as krysolgan, with equally active therapeutic effects in proportion to the gold administered.
Henius and Weiler studied the distribution of gold in the animal body after administration of various gold compounds, finding that lopion accumulated chiefly in the liver, whereas with solganol and sanocrysin the gold was mostly in the kidneys. With solganol an especially large proportion of the gold accumulated in the tuberculous lung. Apparently the bactericidal and inhibitory effects of gold salts depend less upon the anion than upon the strain of tubercle bacilli tested.;
All gold compounds have more or less toxic effects on the kidneys and intestines, apparently because of excretion by these organs. Fischer found sanocrysin particularly toxic to the kidneys, while solganol injured the kidneys least but was toxic to the intestines. Henius and Wissing corroborated the low toxicity of lopion, especially in respect to the kidneys. They observed clinical benefit, but state that it is "Nicht ein besonders wunderwirkendes Heilmittel." Schamberg, Harkins, and Brown, impressed by the fact that of 22 salts of metals and metalloids brought in contact with tubercle bacilli, the gold ion had the highest combining power, have tested several new gold compounds prepared in their laboratory. No effects could be produced in guinea pigs infected subcutaneously, but intradermal infections in rabbits seemed to be somewhat repressed by treatment with gold compounds.
Metal Treatment a la Walbum Another possibility in therapeutics of tuberculosis has been opened by Walbum, who observed that several sorts of metallic elements, given in the form of salts in extremely small doses, greatly modify the immunological response of animals to antigens and infections. With his colleagues he has found that the production of antitoxin, amboceptors, and bactericidal antibodies could be enhanced by injecting optimal minute amounts of salts of several different metals, especially caesium, manganese and iridium. Manganese chloride was found to protect tuberculous guinea pigs from tuberculin shock. Large doses of the metals decrease immunological activity, and there is a great difference in effect with small changes from the optimal concentration, too large doses seeming to stimulate the parasite rather than the defensivle mechanism.
He suggests that perhaps the parasite, protected by its denser outer layers, is unaffected by the small amounts of metal that stimulate the highly differentiated naked cells of the host. This, perhaps, is why there seems to be such a marked discrepancy between the effects in vitro and in vivo, and why the large doses of gold salts used at first were found less useful than smaller doses.
Walbum tested 42 different metals in the treatment of rabbits with tuberculosis that had existed 33 days before beginning the treatment, and found only two, cadmium and manganese, that exhibited a pronounced curative effect. Eight others (cerium, barium, alun,inum, lanthanum, molybdenum, platinum, nickel, and samarium) were said to show a slight effect. The doses used in guinea pigs are extremely minute, e.g., from 0.05 to 3 cc. of a 0.0001 mol. solution, the proper amount being determined by the production of a febrile reaction. Larger than optimum doses are likely to be detrimental. Much less marked results were obtained in guinea pig experiments than with rabbits, but human experiments have been conducted with these undoubtedly harmless quantities of metal salts.
In 1929 Lunde reported on 600 clinical cases treated by Walbum's method during four years, using cadmium, manganese, sanocrysin, beryllium, and aluminum. It is said that the sputum becomes free of tubercle bacilli more frequently, and the recovery is more rapid than was observed before this treatment was instituted. Best results were obtained by using both cadmium and manganese, with beryllium in cases with mixed infection. On the other hand, Larsend and Torning in a small series observed no better results than are generally obtained during sanitarium residence. Frederiksen, however, obtained with manganese injections (0.03 molar) improvement which he likens to that obtained with sanocrysin. There seems to have been no general adoption of this method as a panacea, or even as a remarkably promising advance in the therapy of tuberculosis.
General Considerations Since 1922 we have come to recognize more and more that chemotherapy in the sense in which Ehrlich introduced the term, is more of a dream than a reality. Even his apparent demonstration of the principle with salvarsan turned out to be something quite different from what he had supposed, for it was soon found that salvarsan is not a specific germicide acting on the spirochetes selectively; in fact, it is not very toxic to spirochetes. Apparently it is the disintegration of the salvarsan in the tissues which leads to the production of a partially oxidized derivative which is highly toxic for the parasites. And so we have had to take into consideration other factors, especially the tissue factors, more than we did at first. Particularly, the role of the reticulo-endothelial system has come more into the foreground in chemotherapy, as it has in immunology. In tuberculosis the reticulo-endothelial cells seem to play more than one defensive role. As phagocytes they are of chief importance, most of the tubercle bacilli, after a brief sojourn in the polymorphonuclear leukocytes, being found inside reticulo-endothelial cells. Next, they are the chief cells that form the encapsulating tissue to limit the spread of the infection; and also, it is to be presumed, they act as prime factors in the immunological defense against the tuberde bacilli as they seem to act against other pathogenic bacteria. In addition to this they seem to play a formerly unsuspected role in chemotherapy, for it has been found that if the amount of available reticulo-endothelium is reduced by splenectomy or by blockade, the efficiency of chemotherapeutic agents is correspondingly reduced. (For the literature on this subject, see: Jungeblut and McGinn: J. Exper. Med., 1930, 51, 5.) This may possibly be because the chemotherapeutic agent acts mainly by stimulating the reticuloendothelial cells, or because these cells transform the drug into a more potent form. It is to be noted that most of the chemotherapeutic agents that have seemed to accomplish some increased resistance to tuberculosis, have been substances that are taken up by the reticulo-endothelium. Experiments have shown that introducing moderate amounts of foreign substances into the reticulo-endothelial cells stimulates their activity, only nearly complete saturation reducing their function. Hence it is possible that metal therapy and dye therapy are merely methods for stimulating this defensive mechanism, and not at all a parasiticidal chemotherapy.
Although the last decade has seen an almost complete abandonment of systematic experimental research on the specific chemotherapy of tuberculosis, this fact by no means proves that there remains no possible future for this principle. But it certainly seems reasonable to believe that tuberculosis offers less prospect of early success than almost any other bacterial infection, considering the resistance of the tubercle bacilli and the highly protective wall of active and labile macrophages separating them from the chemotherapeutic agent. We can hardly expect a triumph here before the chemotherapeutic conquest of less resistant organisms in a less protected environment, as with typhoid, erysipelas, bacterial endocarditis, to name a few typical examples.
We may take some hope from the suggestion of Hilgermann (Muinchen. med. Wchnschr., 1930 med. Wchnschr., , 77, 1477 ) that a chemotherapeutic agent that only kills, or renders vulnerable, a few of the infecting bacteria, may turn the scale by virtue of the immunological reactions incited by the destroyed bacteria at the point where the infection exists, for we are learning more and more that local defensive mechanisms are particularly potent (Gay, Cannon). Our fears that the binding effect of blood proteins on our chemotherapeutic agents is too effective to permit them to function are also somewhat allayed by the observation of Wright and Hirschfelder (J. Pharm. & Exper. Ther., 1930, 38, 433 ) that dyes adsorbed on proteins still exhibit antiseptic action; and of the Stearns (J. Exper. Med., 1930, 51, 341) , who found that dyes can act on bacteria even when the blood proteins seem to be in excess, and that apparent disappearance of a dye from the blood does not mean that all bacteriostatic value is lost.
A specific chemotherapy of tuberculosis has not been found, and it may be a long time in coming because of the inherent difficulties of the problem, but it is not a closed chapter. We have some definite facts to go on, and some glimpses of light have been seen. Probably some new success with some other bacterial infection will be needed to stimulate a new attack on the more difficult problem offered by tuberculosis.
